Our Clinical Evidence

A random shuffle method to expand a narrow dataset and overcome the associated challenges in a clinical study: a heart failure cohort example

Fassina L., Faragli A., Lo Muzio F.P., Kelle S., Campana C., Pieske B., Edelmann F. and Alogna A.
November 2020  - Frontiers in Cardiovascular Medicine
Download original document

Out-of-Hospital care of Heart Failure Patients during and after COVID-19 pandemic: time for telemedicine?

Faragli A., La Porta E., Campana C., Pieske B., Kelle S., Koehler F. and Alogna A.
November 2020  - Frontiers in Digital Health
Download original document

Renal dysfunction in cardiovascular diseases and its consequences

Deferrari G., Cipriani A. and La Porta E.
September 2020  - Journal of Nephrology
Download original document

DXA-Derived Visceral Adipose Tissue (VAT) in elderly: percentiles of reference for gender and association with metabolic outcomes

Spadaccini D., Perna S., Peroni G., D’Antona G., Iannello G., Faragli A., Infantino V., Riva A., Petrangolini G., Negro M., Gasparri C. and Rondanelli M.
August 2020  - LIFE
Download original document

The role of non-invasive devices for the telemonitoring of heart failure patients

Faragli A., Abawi D., Quinn C., Cvetkovic M., Schlabs T., Tahirovic E., Düngen H.-D., Pieske B., Kelle S., Edelmann F. and Alogna A.
April 2020  - Heart Failure Reviews
Download original document